A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer (Q40365338)
Jump to navigation
Jump to search
scientific article published on 24 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer |
scientific article published on 24 February 2010 |
Statements
1 reference
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer (English)
1 reference
1 reference
1 reference
M Venturini
1 reference
C Bighin
1 reference
N Olmeo
1 reference
E Aitini
1 reference
G Colucci
1 reference
O Garrone
1 reference
A Paccagnella
1 reference
G Marini
1 reference
L Crinò
1 reference
M Mansutti
1 reference
B Baconnet
1 reference
A Barbato
1 reference
24 February 2010
1 reference
1 reference
Identifiers
1 reference